General Announcement for PLC

29/10/2021

DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS DURING CLOSED PERIOD

UCREST BERHAD

Type Announcement
Subject DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS)
DEALINGS DURING CLOSED PERIOD
Description 
DEALING BY DIRECTOR IN THE SECURITIES OF UCREST BERHAD ("UCREST" OR "THE COMPANY") DURING CLOSED PERIOD

Pursuant to Rule 14.08 of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the following Director of UCrest had transacted as follows:-

 

Name of Director

Date of Dealings

Type of Securities

Price per Securities (RM)

Number of Securities

Percentage of Issued Securities

Nature of Interest

Nature of Transaction

Abdul Razak Bin Dato' Haji Ipap

6.10.2021

Ordinary Shares

0.235

1,000,000

0.1608%

Direct

Disposal of Shares

 

The notice of dealing from Abdul Razak Bin Dato' Haji Ipap was received by the Company on 29 October 2021.



Announcement Info

Company Name UCREST BERHAD
Stock Name UCREST
Date Announced 29 Oct 2021
Category General Announcement for PLC
Reference Number GA1-29102021-00037


Related Announcements for UCREST
Date Title
20/07/2022 OTHERS UCREST BERHAD ("UCREST" OR "THE COMPANY") - SERVICE LEVEL AGREEMENT WITH MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD
23/05/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
14/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
03/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
23/02/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
30/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
26/11/2021 (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST BERHAD'S ("UCREST") WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF
24/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") - MASTER SERVICE AGREEMENT ("MSA") BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF
01/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : INTENTION TO DEAL DURING CLOSED PERIOD
01/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS DURING CLOSED PERIOD